Form D · Pharmaceuticals

Cabinet Health P.B.C.

Washington Dc, DC · CIK 0001860270

Offering snapshot reported Nov 12, 2021 · SEC filing

Reported sold
$5.78M
Offering amount: $6.19M
Investors reported
51
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 26, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.89M$5.78MMay 11, 2021: $3,884,688.00May 11, 2021Nov 12, 2021: $5,775,477.00Nov 12, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,884,688 → $5,775,477

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 12, 2021Amendment$5,775,477$1,890,789vs May 11, 202151SEC filing
May 11, 2021Initial$3,884,688No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-398857

Source: Form D, filed Nov 12, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Russell Gong Director, Executive
Achal Patel Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
30 Florida Avenue Nw Unit 6
Washington Dc, DC, 20001